SCHEMBL26459366

SCHEMBL26459366

CS(=O)(=O)c1cc(/N=N/c2c(O)ccc3ccccc23)ccc1/C=C\c1ccc(/N=N\c2c(O)ccc3ccccc23)cc1S(=O)(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SENP2 Q9HC62 3/20 0.71
▸ SENP1 Q9P0U3 3/20 0.71
▸ SENP7 Q9BQF6 3/20 0.71
▸ SUMO2 P61956 2/20 0.71
▸ SUMO1 P63165 2/20 0.71
▸ SENP3 Q9H4L4 2/20 0.71
▸ GLO1 Q04760 2/20 0.61
▸ MPL P40238 6/20 0.59
▸ CTRC Q99895 2/20 0.59
▸ MAPT P10636 5/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ TDP1 Q9NUW8 3/20 0.58
▸ GAA P10253 2/20 0.58
▸ MAPK1 P28482 2/20 0.58
▸ MEN1 O00255 3/20 0.53
▸ THRB P10828 3/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26460901 0.84 SENP2 (0.62) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL4059042 0.83 SENP2 (1.00) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL29776745 0.83 SENP2 (1.00) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL29555761 0.83 SENP2 (1.00) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL4059056 0.83 SENP2 (1.00) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL10724094 0.83 GLO1 (0.82) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL10724086 0.83 GLO1 (0.82) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL26459479 0.82 SENP2 (0.70) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL10723387 0.82 GLO1 (0.80) SENP2SENP1SENP7SUMO2SUMO1
SCHEMBL10723402 0.82 GLO1 (0.80) SENP2SENP1SENP7SUMO2SUMO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION KEAP1, HMOX1, NFE2L2 SENP2 2951/4885SENP1 2007/4885SENP7 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback